Functional effects of genetic variants in the 11β-hydroxylase (CYP11B1) gene

被引:15
|
作者
Barr, Marianne
MacKenzie, Scott M.
Wilkinson, Donna M.
Holloway, Christine D.
Friel, Elaine C.
Miller, Stephen
MacDonald, Tom
Fraser, Robert
Connell, John M. C.
Davies, Eleanor
机构
[1] Univ Glasgow, BHF GCRC, Div Cardiovasc & Med Sci, Blood Pressure Grp, Glasgow G12 8TA, Lanark, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Dundee DD1 9SY, Scotland
基金
英国医学研究理事会;
关键词
ALDOSTERONE SYNTHASE GENE; CONGENITAL ADRENAL-HYPERPLASIA; SINGLE-NUCLEOTIDE POLYMORPHISMS; ESSENTIAL-HYPERTENSION; ANGIOTENSIN-II; BLOOD-PRESSURE; AMINO-ACID; DEFICIENCY; MUTATIONS; PREVALENCE;
D O I
10.1111/j.1365-2265.2006.02673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We previously described an association between the -344C/T 5'-untranslated region (UTR) polymorphism in the CYP11B2 (aldosterone synthase) gene and hypertension with a raised aldosterone to renin ratio (ARR); the same genetic variant is also associated with impaired adrenal 11 beta-hydroxylase efficiency. The -344 polymorphism does not seem to be functional, so is likely to be in linkage with variants in CYP11B1 that determine the associated variation in 11 beta-hydroxylase efficiency. We therefore aimed to determine whether there is an association between CYP11B1 variants and hypertension and/or an altered ARR. Design and measurements We screened 160 subjects divided into four groups, normotensive controls, unselected hypertensive subjects, and hypertensive subjects with either a high (>= 750) or low ARR (<= 200), for variants in the coding region of CYP11B1 by single-stranded conformation polymorphism (SSCP) and direct sequencing. The effects of these variants on enzyme function were assessed by conversion of 11-deoxycortisol to cortisol and 11-deoxycorticosterone (DOC) to corticosterone. Results Eight novel missense mutations were identified in the CYP11B1 gene that alter the encoded amino acids: R43Q, L83S, H125R, P135S, F139L, L158P, L186V and T196A. In each case they were heterozygous changes. However, no mutations were identified that could account for hypertension and/or a raised ARR. The variants L158P and L83S severely impaired enzyme function while R43Q, F139L, P135S and T196A enzymes resulted in product levels that were approximately 30-50% that of wild-type levels. The variant enzymes H125R and L186V resulted in substrate-specific alterations in enzyme function. H125R decreased conversion of 11-deoxycortisol to cortisol and L186V increased 11-deoxycortisol conversion. Neither had an effect on the conversion of DOC to corticosterone. Conclusion No variants were identified in the coding region of CYP11B1 that could account for hypertension and/or a raised ARR. However, this in vitro study identifies the importance of these affected residues to enzyme function and will inform subsequent studies of structure-function relationships.
引用
收藏
页码:816 / 825
页数:10
相关论文
共 50 条
  • [31] Case Report: A combination of chimeric CYP11B2/CYP11B1 and a novel p.Val68Gly CYP11B1 variant causing 11β-Hydroxylase deficiency in a Chinese patient
    Li, Jialin
    Zhang, Fenglan
    Xu, Miao
    Qiu, Hao
    Zhou, Cheng
    Li, Li
    Qin, Lan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations
    Menabo, Soara
    Polat, Seher
    Baldazzi, Lilia
    Kulle, Alexandra E.
    Holterhus, Paul-Martin
    Groetzinger, Joachim
    Fanelli, Flaminia
    Balsamo, Antonio
    Riepe, Felix G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2014, 22 (05) : 610 - 616
  • [33] Steroid 11β-hydroxylase deficiency-focusing on the CYP11B2/CYP11B1 chimera which has been recently discovered as the causing gene
    Kuribayashi, Isao
    SEIKAGAKU, 2006, 78 (08): : 749 - 755
  • [34] Neonatal salt-wasting and 11 β-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 β-hydroxylase)
    Ezquieta, B
    Luzuriaga, C
    CLINICAL GENETICS, 2004, 66 (03) : 229 - 235
  • [35] Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations
    Soara Menabò
    Seher Polat
    Lilia Baldazzi
    Alexandra E Kulle
    Paul-Martin Holterhus
    Joachim Grötzinger
    Flaminia Fanelli
    Antonio Balsamo
    Felix G Riepe
    European Journal of Human Genetics, 2014, 22 : 610 - 616
  • [36] A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report
    Yuan, Xianxian
    Lu, Lin
    Chen, Shi
    Jiang, Jun
    Wang, Xiangqing
    Liu, Zhihui
    Zhu, Huijuan
    Pan, Hui
    Lu, Zhaolin
    BMC ENDOCRINE DISORDERS, 2018, 18
  • [37] Donor splice mutation in the 11β-hydroxylase (CYP11B1) gene resulting in sex reversal:: A case report and review of the literature
    Bhangoo, Amrit
    Wilson, Robert
    New, Maria I.
    Ten, Svetlana
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (10): : 1267 - 1282
  • [38] STEROID 11-BETA-HYDROXYLASE DEFICIENCY CAUSED BY A 5 BASE-PAIR DUPLICATION IN THE CYP11B1 GENE
    SKINNER, CA
    RUMSBY, G
    HUMAN MOLECULAR GENETICS, 1994, 3 (02) : 377 - 378
  • [39] Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene
    Fardella, CE
    Pinto, M
    Mosso, L
    Gómez-Sánchez, C
    Jalil, J
    Montero, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10): : 4805 - 4807
  • [40] A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency
    Zhang, Manna
    Liu, Yanling
    Sun, Shouyue
    Zhang, Huijie
    Wang, Weiqing
    Ning, Guang
    Li, Xiaoying
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 133 : 25 - 29